ArticlePloS one2026
Investigating the antioxidant, antibacterial, and antifungal properties of typha domingensis leaves assisted synthesized zinc oxide nanoparticles.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Remedial applications of biosynthesized metal oxide nanoparticles against pathogenic microorganisms.Discover nano · 2026Review
- Zinc oxide-bacteriophage synergistic combination for dual-mode antibacterial activity against multidrug-resistant Escherichia coli.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Green-synthesized nanoparticles (NPs) offer unique properties over traditional approaches, with applications in coatings, catalysts, packaging, environmental cleaning, and medicine. This research involves the synthesis of Zinc oxide nanoparticles (ZnO NPs) utilizing aqueous leaf extract of Typha domingensis (locally known as Hogla pata) as a reducing agent. The biosynthesized NPs were then characterized using ultraviolet-visible spectroscopy (UV-Vis), Fourier transform infrared (FTIR) spectroscopy, field emission scanning electron microscopy (FESEM), and energy-dispersive X-ray (EDX) spectroscopy. The XRD result revealed that the synthesized NPs were enriched with (101) facets, which were similar to the standard JCPDS card no 00-036-1451. The size of the ZnO NPs was determined from XRD data utilizing the Debye-Scherrer equation and found to be around 26.74 nm. Moreover, the SEM analysis showed that the shape of the NPs was agglomerated spherical. The 2,2-diphenyl-1-picrylhydrazyl (DPPH) free radical showed dose-dependent antioxidant activity against synthesized ZnO NPs, with an average IC50 of 32.25 µg/mL. The antibacterial efficacy of green-synthesized ZnO NPs was assessed against fungal and bacterial pathogens in antifungal experiments. Colletotrichum sp. showed the highest sensitivity to ZnO NPs, with a 20 ± 0.80 mm zone of inhibition (ZOI) and 22.22% inhibition, whereas Fusarium sp. had a 17 ± 0.68 mm ZOI and 18.89% inhibition at a dosage of 2 mg/mL. ZnO NPs also exhibited antibacterial activity against two gram-negative bacteria, Coliform sp. and Salmonella sp., both demonstrating a 12 mm ZOI and 13.33% inhibition at 5.0 mg/mL. These results demonstrate that ZnO NPs biosynthesized with Typha domingensis leaf extract exhibit versatile antimicrobial and antioxidant properties, offering a safe and sustainable alternative to synthetic compounds.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.